(A) Real-time PCR of DCIScnt2cy and DCISCAF2cy using the indicated primers. The DCIScnt2cy and DCISCAF2cy were extracted from tumor xenografts generated by DCIS cells admixed with control fibroblasts and CAFs expressing GFP or TβRII ecto, respectively. (B) Real-time PCR of DCIScnt1cy and DCISCAF1cy expressing the indicated shRNAs measuring E-cad expression. The DCIScnt1cy and DCISCAF1cy were extracted from 30-d-old tumor xenografts generated by DCIS cells expressing the indicated shRNAs admixed with control fibroblasts and CAFs, respectively. (C) Immunofluorescence of DCIS cells treated with recombinant SDF-1 (100 ng/ml) and/or TGF-β1 (10 ng/ml) for 48 h using anti–E-cad or ZEB1 antibody. E-cad+ cancer cells (simple arrows) and nuclear ZEB1+ cancer cells (triangular arrows) are shown. Scale bars, 10 μm. (D) Real-time PCR of MCF-7-ras cells treated with recombinant SDF-1 and/or TGF-β1 for 24 h to measure the indicated gene expressions. Data information: Asterisk indicates a significant difference relative to DCISCAF2cy extracted from tumor with CAFs expressing GFP (A) and GFP-shRNA–expressing DCISCAF1cy (B), and between the depicted groups (D). t test (A, B, D). n.s.: not significant (D). Error bars, SE.